Becton Dickinson & Co
BDX
212.78
+0.10
+0.05%
Becton Dickinson & Co
US · BDX
#450 by market cap
Listed 1970
212.78
+0.10
+0.05%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 97.28% -0.09pp
- Institutions
- 1,769 -5
- As of
- 2026/Q4 vs. prior period
Holder types
Mutual Fund83.73%
Public Company3.43%
Hedge Fund2.65%
Private Company2.39%
Government Pension Fund1.97%
Sovereign Wealth Fund1.58%
Insurance Company0.77%
Family Office/Trust0.28%
Individual/Insider0.17%
Other3.03%
Top holders as of 2026-09-30
BlackRock
8.67% · 23.62M sh
Vanguard Capital Management, LLC
7.11% · 19.36M sh
State Street Global Advisors
5.58% · 15.21M sh
Vanguard Portfolio Management, LLC
5.40% · 14.70M sh
First Eagle Investment Management, LLC
5.10% · 13.88M sh
Geode Capital Management, LLC
2.97% · 8.09M sh
Invesco Ltd.
2.72% · 7.40M sh
Putnam LLC
2.65% · 7.22M sh
MFS Investment Management
2.49% · 6.78M sh
T. Rowe Price Group, Inc.
2.40% · 6.54M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 25 buys · 20 sells
| Name | Role | Stake |
|---|---|---|
| Thomas Polen | Chairperson & CEO | 0.04% |
| Timothy Ring | Independent Director | 0.02% |
| Bilal Muhsin | Executive VP & President of Future Connected Care Segment | 0.02% |
| Bertram Scott | Independent Director | 0.01% |
| Christopher Ian Jones | Independent Director | 0.01% |
| Shana Neal | Former Chief Human Resources Officer | 0.01% |
| Michael Feld | Chief Revenue Officer | 0.01% |
| Christopher DelOrefice | Former Chief Financial Officer | 0.01% |
| Roland Goette | Former Executive VP & President of EMEA | 0.01% |
| Michael Garrison | Former Executive VP & President of Medical Segment and BioPharma Systems Segments | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-05 | Robert Huffines | Independent Director | Other Derivative Acquisition | +158 | -- |
| 2026-11-05 | Carrie Byington | Independent Director | Other Derivative Acquisition | +79 | -- |
| 2026-11-04 | Thomas Polen | Chairperson & CEO | Derivative Exercise and Sale | -20,239 | $178.94–210.00 |
| 2026-10-25 | Michael Feld | Chief Revenue Officer | Automatic Disposition | -76 | $198.13 |
| 2026-09-27 | Michael Feld | Chief Revenue Officer | Automatic Disposition | -76 | $183.70 |
| 2026-09-01 | vitor Roque | Chief Financial Officer | Sale to Issuer | -190 | -- |
| 2026-08-25 | Michael Feld | Chief Revenue Officer | Automatic Disposition | -165 | $188.49 |
| 2026-08-19 | Michael Feld | Chief Revenue Officer | Sale to Issuer | -1,049 | -- |
| 2026-08-12 | Thomas Polen | Chairperson & CEO | Derivative Exercise and Sale | -43,278 | $167.25–185.00 |
| 2026-08-10 | Roland Goette | Former Executive VP & President of EMEA | Open Market Disposition | -2,438 | $180.84 |
| 2026-08-05 | Robert Huffines | Independent Director | Other Derivative Acquisition | +189 | -- |
| 2026-08-05 | Carrie Byington | Independent Director | Other Derivative Acquisition | +94 | -- |
| 2026-07-26 | Michael Feld | Chief Revenue Officer | Automatic Disposition | -75 | $157.13 |
| 2026-07-01 | Bilal Muhsin | Executive VP & President of Future Connected Care Segment | Sale to Issuer | -1,935 | -- |
| 2026-06-30 | Bilal Muhsin | Executive VP & President of Future Connected Care Segment | Other Acquisition | +14,342 | -- |
| 2026-06-25 | Michael Feld | Chief Revenue Officer | Automatic Disposition | -75 | $152.80 |
| 2026-06-23 | Michael Garrison | Former Executive VP & President of Medical Segment and BioPharma Systems Segments | Automatic Disposition | -1,100 | $145.66 |
| 2026-06-21 | Manish Sinha | Executive Vice President | Initial Statement of Beneficial | 0 | -- |
| 2026-06-09 | Michael Garrison | Former Executive VP & President of Medical Segment and BioPharma Systems Segments | Automatic Disposition | -1,100 | $151.48 |
| 2026-05-31 | Thomas Polen | Chairperson & CEO | Derivative Exercise and Sale | -20,209 | $126.16–146.35 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Becton Dickinson & Co discussion 0 comments